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Purpose: The nephrotic syndrome (NS) is characterized by the favorable response 
to glucocorticoid therapy and the development of NS may be associated with dys-
functional immune systems. In order to investigate the serum immunoglobulin E 
(IgE) levels and cytokines activity in pediatric NS, the total of 32 steroid responsive 
NS patients and 5 healthy controls were enrolled in this study. Materials and Meth-
ods: All patients were divided into two groups according to the initial serum IgE lev-
els, such as normal and high IgE group, and their clinical characteristics were evalu-
ated. In addition, serum levels of interleukin (IL)-4, IL-5, IL-10 and transforming 
growth factor (TGF)-β were compared and correlated with serum albumin, protein-
uria by means of disease severity, and cytokines. Results: In the high IgE group, the 
higher comorbidity of allergic diseases and relapsing rate, the longer duration of ste-
roid therapy before initial remission, and the higher serum IL-4 and IL-5 levels were 
found. In all patients, initially higher serum levels of IL-4 and IL-5 declined to nor-
mal levels after steroid therapy, whereas the serum IL-10 levels showed no signifi-
cant difference between nephrotic phase (heavy proteinuria) and remission phase (no 
proteinuria) of NS. The serum TGF-β levels of the nephrotic phase were significant-
ly lower than those of remission phase or control group, and returned to normal con-
trol levels after steroid therapy. Conclusion: This study indicates that initial IgE level 
is associated with steroid responsiveness and disease severity, and cytokine activities 
may also be related to the pathogenesis of pediatric steroid responsive NS.
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INTRODUCTION
Idiopathic nephrotic syndrome (NS) is characterized by generalized edema, heavy 
proteinuria, hypoalbuminemia, and hyperlipidemia, and minimal change disease 
(MCD) is the most common form of idiopathic NS, accounting for 90% of pa-
tients under the age of 10 years and more than 50% of older children.1,2
Although the etiology of idiopathic NS is unknown, several candidate factors 
have been identified. After the first report of hypersensitivity and NS by Hard-You Sook Youn, et al.
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national Study of Kidney Disease in Children.16 Five healthy 
children (1 boy and 4 girls, aged 6 to 8 years) were includ-
ed as normal control group.
Study design
The children during their first episode of NS were admitted 
to the pediatric wards prior to steroid treatment, and clinical 
data including age, gender, and blood pressure were collect-
ed. The blood sample was drawn to evaluate white blood 
cell count, eosinophil count, platelet, protein, albumin, cho-
lesterol, triglyceride, blood urea nitrogen, creatinine, elec-
trolytes, and various immune mediators, such as comple-
ment 3 and 4, antineutrophil antibody, antistreptolysin O 
and C-reactive protein.  
The proteinuria, hematuria and renal functions were 
screened by spot and 24-hour urine analysis. When MCD 
was presumed, prednisolone therapy was initiated at a dose 
of 60 mg/m2/day after confirming a negative purified pro-
tein derivative skin test. 
All of the steroid responsive NS patients were divided into 
a normal IgE group and a high IgE group according to the 
initial serum IgE levels. The patients who showed higher IgE 
levels, measuring more than upper 2 standard deviation score 
of the age-adjusted reference range, were defined as high IgE 
group.17 Remission was characterized by a marked reduction 
in proteinuria (to <4 mg/m2/hr or urine albumin dipstick of 0 
to trace for 3 consecutive days) in association with resolution 
of edema and normalization of serum albumin to at least 3.5 
g/dL. Relapse was defined as recurrence of massive protein-
uria (>40 mg/m2/hr, urine protein/creatinine ratio >2.0 mg/
mg, or urine albumin dipstick ≥2+ on 3 consecutive days), 
most often in association with recurrence of edema.2
 
Measurement of the serum immunoglobulin and 
cytokine levels
During the nephrotic phase prior to steroid treatment and 
remission phase, the serum was separated from whole 
blood and was kept at -70°C for immune cytokine assay. 
The serum IgE levels were analyzed by Hitachi optigen 
allergen specific IgE assay system Korean inhaler panel 
(Hitachi chemical diagnostic, Inc., Mountain View, CA, 
USA) based on manufacturer’s method. The serum levels 
of IgG, IgA, and IgM were determined by standard en-
zyme immunoassay techniques (Seiken, Denka Seika, Ni-
gata-ken, Japan).  
The serum IL-4, IL-5 and TGF-β levels were measured by 
human platinum enzyme-linked immunosorbent assay (ELI-
wicke3 in 1959, numerous studies have reported an associa-
tion between NS and allergy.4,5 Several studies have dem-
onstrated elevated serum immunoglobulin E (IgE) levels in 
NS patients and hypothesized its active role in the patho-
physiology, however, a direct relationship between IgE and 
the pathogenesis of NS is controversial.6,7
Meanwhile, it was proposed that abnormal T cell response 
and Th2 cytokines are strongly related to the pathogenesis of 
NS.6,8 Various evidences indicate that lymphocytes derived 
from an abnormal immune system alter the permeability of 
the glomerular capillary wall, suggesting that immune dys-
function plays a key role in the pathogenesis of NS.8-11 Acti-
vated macrophages and Th2 lymphocytes may be involved 
in the pathogenesis of NS, and T-cell dysfunction leads to 
changes in cytokines, causing a loss of negatively charged 
glycoproteins within the glomerular capillary wall.12,13 
Recently, regulatory T cells (Treg) and T-helper17/Treg 
imbalance has also been suggested as a potential factor in 
the pathogenesis of MCD and Treg dysfunction and de-
crease of their related cytokines, transforming growth fac-
tor (TGF)-β and interleukin (IL)-10, have been reported.14,15 
Especially, TGF-β was suggested as a protective cytokine.14
In this study, we evaluated the clinical characteristics of 
pediatric steroid-responsive NS patients according to the 
initial serum IgE levels, and several immune mediators 
such as Th2 cytokines (IL-4, IL-5) and Treg related cyto-
kines (TGF-β, IL-10) were compared according to their re-
mission status. 
MATERIALS AND METHODS
　　　
Patients
The study protocol was conducted after approval by the In-
stitutional Review Board of Chungnam National University 
Hospital, Daejeon, Korea and was carried out after informed 
consent was obtained from the patients or their legitimate 
guardians.
From September, 2004 to July, 2010, the total of 32 pa-
tients (21 boys and 11 girls, aged 1.8 to 13.9 years) who un-
derwent prednisolone therapy (17 steroid-sensitive and 15 
steroid-dependent) for idiopathic nephrotic syndrome at the 
Department of Pediatrics, Chungnam National University 
Hospital were enrolled in this study (Table 1). The median 
duration of follow-up was 4.7 years. The patients with con-
genital or secondary renal diseases were excluded. The di-
agnostic criteria for idiopathic NS were based on the Inter-The Clinical and Cytokine Characteristics of Steroid Responsive Nephrotic Syndrome
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and 5 girls) who had normal IgE levels and 20 patients (14 
boys and 6 girls) who had high IgE levels. The clinical 
characteristics among the groups were compared by Mann-
Whitney U test and Fisher’s exact test. At the time of initial 
diagnosis, the data of their age, gender, and the laboratory 
findings of blood chemistry such as white blood cell count, 
eosinophil count, serum protein, albumin, cholesterol, IgG, 
IgA, IgM, immune mediators, and 24-hour urine protein/
creatinine did not show any significant differences between 
the two groups (Table 2). However, the duration of clinical 
remission was significantly shorter in the normal IgE group 
than in the high IgE group (p=0.005). The relapse rate 
(p=0.003) and the concomitant allergic diseases (p<0.001) 
were more frequent in the high IgE group. The median 
(range) time to the initial remission was 8.5 (7.0-12.0) days 
in the normal IgE group and 12.5 (8.0-32.0) days in the 
high IgE group (p=0.005) and the median (range) duration 
of total steroid therapy was 4.0 (2.5-22.0) months in the 
normal IgE group and 54.0 (3.0-108.0) months in the high 
IgE group (p=0.006) (Table 2). Total follow-up durations of 
SA) kit (eBioscience, San Diego, CA, USA). The serum IL-
10 levels were detected by human high sensitivity ELISA kit 
(eBioscience). Briefly, standard dilutions and samples were 
pipetted into the wells. And the concentrated streptavidin-
horseradish peroxidase solution was added to all the wells. 
After a wash to remove any unbound reagent, a TMB sub-
strate solution was added to the wells and the intensity of the 
color was measured by a spectrophotometer at 450 μm.
Statistics analysis
The clinical and laboratory information of the NS patients 
were expressed as a median and range (minimum to maxi-
mum) by frequent analysis. The configuration with NS pa-
tients between normal IgE and high IgE levels were ana-
lyzed by using Mann-Whitney U test and Fisher’s exact test. 
The Kruskall-Wallis test and Scheffe’s post hoc comparison 
were used to compare the cytokines between NS patients 
with nephrotic and remission phase and healthy controls. 
Significant correlation between circulating cytokines and 
serum albumin levels was assessed by linear regression analy-
sis. The data were analyzed using SPSS version 12.0 for Win-
dows (SPSS Inc., Chicago, IL, USA), and a p value<0.05 was 
considered significant.
RESULTS
 
Clinical outcomes according to the initial serum IgE 
levels
Subjects were divided into two groups; 12 patients (7 boys 
Table 1. The Profile of Nephrotic Syndrome Patients 
Patients (n=32)
Age (yrs) 4.8 (1.8-13.9)*
Sex (M : F) 21 : 11
Follow-up duration (yrs) 4.7 (0.1-17.3)*
Steroid-responsiveness
    Non-relapse, n (%) 17 (53.1)
    Relapse, n (%) 15 (46.9)
*Median (range).
Table 2. The Comparison of Clinical Characteristics of Nephrotic Syndrome according to the Initial Serum IgE Levels
Parameters Normal IgE (n=12) High IgE (n=20) p value*
Age (yrs)    6.6 (2.7-11.0)    4.7 (1.8-13.9) 0.185
Sex (M : F) 7 : 5 14 : 6 0.672
Protein (mg/dL)    3.9 (3.4-4.6)    3.9 (3.2-4.8) 0.893
Albumin (mg/dL)    1.5 (1.1-2.5)    1.6 (0.8-2.3) 0.954
Cholesterol (mg/dL)   410 (170-738)   392 (286-563) 0.716
IgG (mg/dL)   320 (144-749)   297 (102-636) 0.632
IgA (mg/dL)   105 (35-591)     94 (41-232) 0.526
IgM (mg/dL)   184 (11-448)   230 (82-411) 0.454
Urine protein/Creatinine  5.14 (1.30-21.05)  5.92 (0.79-31.29) 0.716
WBC (/mm
3) 8335 (4830-15560) 9185 (2560-19850) 0.924
Esoinophil count (/mm
3)   136 (0-613)   166 (0-1145) 0.604
Initial remission (day)    8.5 (7.0-12.0)  12.5 (8.0-32.0) 0.005
Relapse, n (%)       2 (16.7)     14 (70.0)  0.003
Allegy history, n (%)       2 (16.7)     17 (85.0) <0.001
Duration of steroid therapy (month)    4.0 (2.5-22.0)  54.0 (3.0-108.0) 0.006
IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; WBC, white blood cell.
*Results of the Mann-Whitney U test and Fisher's exact test.You Sook Youn, et al.
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The serum levels of IL-5 were higher also in the nephrot-
ic phase patient than those of remission phase of NS 
(p=0.051) and controls (p=0.028), but there were no signifi-
cant differences between the patients with remission phase 
and control group (p=0.858) (Fig. 3B). The serum levels of 
IL-10 did not show any differences between both groups 
(Fig. 3C).
The serum levels of TGF-β in the nephrotic phase of NS 
patients were significantly lower than those of remission 
phase (p<0.001) and control group (p<0.001). However, 
there was no statistically significant difference between pa-
tients with remission phase and control group (p=0.576) 
(Fig. 3D).
Correlation between serum albumin and cytokines
Linear regression analysis showed that the serum levels of 
IL-4 had a negative correlation with that of albumin (R2= 
0.259, p=0.004) (Fig. 4A), while the serum levels of IL-5 
and IL-10 did not show any correlations with that of albu-
min (R2=0.170, p=0.113 and R2=0.001, p=0.571, respective-
ly) (Fig. 4B and C). On the other hand, the serum level of 
TGF-β had a positive correlation with that of albumin 
(R2=0.501, p<0.001) (Fig. 4D).
DISCUSSION
The pathogenesis of idiopathic NS is not thoroughly under-
stood. However, the hypothesis was put forward in 1974 
that idiopathic NS is an immune disorder with increased 
levels of lymphocyte-derived permeability factors. Since 
two groups were same.
Comparison of serum cytokines according to the serum 
IgE levels
In the normal IgE group, the median (range) initial serum 
levels of each IL-4 and IL-5 were 1.3 (1.0-1.4) and 1.3 (0.9-
1.4) pg/mL, respectively. In the high IgE group, the serum 
levels of IL-4 and IL-5 was 1.9 (1.0-6.2) and 2.0 (1.1-4.4) 
pg/mL, respectively. Initial serum levels of IL-4 (p=0.018) 
and IL-5 (p=0.039) were significantly higher in the high 
IgE group than in the normal IgE group (Fig. 1). However, 
the serum levels of IL-10 and TGF-β showed no difference 
between them (data are not shown). 
Comparison of serum IgE levels according to the 
remission state
There were no changes in the median (range) levels of se-
rum IgE according to the treatment state (nephrotic or re-
mission phase) between the normal and high IgE groups 
(Fig. 2).
Changes of serum cytokines according to the disease 
activity
To explore the disease activities and the roles of cytokines, 
the serum levels of IL-4, IL-5, IL-10, and TGF-β were ex-
amined in both NS patients and healthy controls. The se-
rum levels of IL-4 were significantly higher in the nephrot-
ic phase of NS than in the remission phase (p<0.001) and 
control group (p<0.001). However no difference was found 
between remission phase of NS and control group (p=0.991) 
(Fig. 3A).
Fig. 1. Comparisons of the serum IL-4 and IL-5 levels according to the se-
rum IgE levels. Initial serum IL-4 and IL-5 levels were significantly higher in 
the high IgE group than in the normal IgE group. IgE, immunoglobulin E; IL, 
interleukin.
Fig. 2. Comparison of serum IgE levels according to the remission state. 
There were no changes in the median (range) levels of serum IgE accord-
ing to the treatment state (nephrotic or remission phase) between the nor-
mal (p=0.667) and high IgE groups (p=0.131). IgE, immunoglobulin.
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Fig. 3. Comparisons of the cytokines between nephrotic syndrome patients and healthy controls. (A) The serum levels of IL-4 in nephrotic syndrome patients 
with nephrotic phase were significantly higher than those of remission phase and controls. (B) The serum levels of IL-5 in nephrotic phase were also higher 
than those of normal controls. (C) The serum IL-10 levels did not show any significant differences in each group. (D) In the patients with nephrotic phase, the 
serum levels of TGF-β were significantly lower than those of remission phase or control group. This were calculated by using Kruskal-Wallis test Scheffe’s 
post hoc comparison. The **means p<0.001, and *indicates p<0.05. IL, interleukin; TGF, transforming growth factor; NS, nephrotic syndrome.
Fig. 4. Correlations between serum cytokines and albumin levels. By linear regression analysis, (A) the serum IL-4 levels had a negative correlation with se-
rum albumin (p=0.004), (B) the serum IL-5 levels had no correlation with serum albumin (p=0.113), (C) the serum IL-10 levels did not have a positive correla-
tion with serum albumin levels (p=0.571), whereas (D) the serum TGF-β levels had (p<0.001). IL, interleukin; TGF, transforming growth factor.
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pathic NS are driven toward the Th2 phenotype.13 
IL-4 is the most important Th2 cytokine which mediates 
IgE synthesis.24 In NS, IL-4 can act on glomerular visceral 
epithelial cells by binding IL-4 receptor, and plays a role in 
glomerular permeability.25 This suggests that, regardless of 
atopy, IL-4 may be one of the cytokines associated with the 
pathogenesis of proteinuria and also be a predictive factor 
for disease severity in NS. In our present study, the serum 
levels of IL-4 were higher in the nephritic phase of NS than 
the remission phase and control group and were correlated 
with serum albumin levels. However, this seems to be vari-
ance with the results in many previous studies that serum 
IL-4 levels decreased during relapse but increased in ne-
phritic patients with long-term remission.26 
Several authors have reported that serum IL-5 levels in 
the nephrotic phase were higher than in the remission phase 
and Ohtomo, et al.27 reported that suplatast tosilate, which 
suppresses IL-4 and IL-5 production, was effective for ste-
roid reduction in idiopathic steroid sensitive NS.13,23 We 
also found that serum IL-5 levels were higher in the ne-
phrotic phase than in the remission phase with steroid treat-
ment. However, because other hither-to-uncharacterized 
factors might have been needed to induce idiopathic NS, 
further studies should be conducted to clarify the effects of 
IL-4 and IL-5 on idiopathic NS.
Recently, regulatory T cells (Treg cells) have been de-
scribed as subsets distinct from Th1 and Th2 cells. Treg 
cells expressing the forkhead/winged helix transcription 
factor (Foxp3) have an anti-inflammatory role and maintain 
tolerance to self-components through direct contact with 
cells or by releasing anti-inflammatory cytokines such as 
IL-10 and TGF-β.28,29 Treg cell dysfunction has been found 
in several kidney disease animal models.30-32 A reduction in 
Treg cells induces local tissue inflammation, which may be 
related to the pathogenesis of proteinuria and the propaga-
tion of idiopathic NS.33 In relapsed idiopathic minimal NS, 
Treg cells have an impaired capacity to suppress T-effector-
cell proliferation.14 Liu, et al.15 reported that Th17/Treg ra-
tios were increased along with increased proteinuria and 
decreased albumin levels in adult patients with minimal 
change NS.
TGF-β has been shown to regulate both immunogenic 
and immunosuppressive response, depending on the cellular 
environment.34 Therefore, overall systemic effects of TGF-β 
must be understood within the context of other collaborative 
networks involving other immunoregulatory signals. 
TGF-β is often associated with the progression of kidney 
then, numerous lines of evidence have been presented, sug-
gesting that immune mediators play a pivotal role in its 
pathogenesis.6-8,10,18
Although a pathogenic relationship remains to be con-
firmed, the serum levels of IgE show a close relationship to 
NS, and many studies have shown a strong association be-
tween idiopathic NS and atopic disorders.4,5 IgE levels were 
significantly higher in NS patients with atopy than in non-
atopic patients, especially during the relapse phase of NS 
compared with the remission phase, implicating IgE as a 
barometer of disease severity and giving it prognostic val-
ue.6,19 In our present study, in a comparison of the clinical 
characteristics of NS patients with normal IgE and those 
with high IgE, the high-IgE group required a significantly 
longer time to reach their initial remission, was more sus-
ceptible to frequent relapse and comorbid allergic diseases, 
and required longer steroid therapy to recover from the ne-
phrotic phase than the normal-IgE group. Serum IgG levels 
were lower in NS patients, whereas the levels were not dif-
ferent between the normal- and high-IgE groups. It is not 
certain whether the increased levels of IgE in idiopathic NS 
are pathogenic or co-incident, nevertheless, our results sug-
gest that the regulation of total IgE production correlates 
with the disease activity and outcome of NS.20 However, it 
should be noted that part of the nephrotic children had per-
sistently normal serum IgE levels, indicating different etiol-
ogies in the pathogenesis of NS.  
The signals for IgE synthesis are delivered by IL-4 or IL-
13. In relapsed NS, activated T cells increase the secretion of 
IL-4 and IL-13, which could induce isotype switching in 
IgE. IL-5 also promotes the production of IgE, whereas 
IFN-γ inhibits the secretion of IgE.13,21,22 In our study, high-
IgE group displayed significantly elevated serum IL-4 and 
IL-5 levels. Thus, we suggest that the increased production 
of IL-4 and IL-5 in idiopathic NS may indicate that these 
cytokines are involved in the enhanced production of serum 
IgE. Furthermore, allergic treatment alone could not induce 
the remission of NS, suggesting that the elevated serum IgE 
in some patients can not cause their NS, but rather reflects 
allergic responses to the perturbation of their humoral im-
munity.4,23
In order to evaluate immunologic pattern and their modu-
lating serum cytokines and to analyze the correlation with 
disease activity in children with idiopathic NS, we evaluat-
ed initial serum levels of IL-4, IL-5, IL-10 and TGF- β and 
their kinetics during treatment with or without relapse. A 
number of reports have shown that activated T cells of idio-The Clinical and Cytokine Characteristics of Steroid Responsive Nephrotic Syndrome
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